535.80
0.96%
ICICI Securities Limited
Suven is currently on a three pronged investment plan, 1) Relocating R&D centre, 2) Replacement and upgradation of blocks at Suryapet facility and 3) Additional new block in line with FDA regulations at Pashamylaram facility...
Cohance Lifesciences.. has an average target of 984.00 from 2 brokers.
More from Cohance Lifesciences Ltd.
Recommended